455
Views
89
CrossRef citations to date
0
Altmetric
Review

Treatment adherence in hemophilia

&
Pages 1677-1686 | Published online: 27 Sep 2017

References

  • Bolton-MaggsPHPasiKJHaemophilias A and BLancet200336193711801180912781551
  • MannucciPMTuddenhamEGThe hemophilias: from royal genes to gene therapyN Engl J Med2001344231773177911396445
  • BerntorpEShapiroADModern haemophilia careLancet201237998241447145622456059
  • Manco-JohnsonMJAbshireTCShapiroADProphylaxis versus episodic treatment to prevent joint disease in boys with severe hemophiliaN Engl J Med2007357653554417687129
  • IorioAMarchesiniEMarcucciMStobartKChanAKClotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BCochrane Database Syst Rev20119CD00342921901684
  • PanickerJWarrierIThomasRLusherJMThe overall effectiveness of prophylaxis in severe haemophiliaHaemophilia20039327227812694517
  • FischerKvan der BomJGMolhoPProphylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcomeHaemophilia20028674575212410642
  • GringeriALundinBvon MackensenSMantovaniLMannucciPMA randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT study)J Thromb Haemost20119470071021255253
  • IngerslevJLethagenSPoulsenLHLong-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patientsHaemophilia2014201586424354479
  • LöfqvistTNilssonIMBerntorpEPetterssonHHaemophilia prophylaxis in young patients: a long-term follow-upJ Intern Med199724153954009183307
  • NilssonIMBerntorpELöfqvistTPetterssonHTwenty-five years’ experience of prophylactic treatment in severe haemophilia A and BJ Intern Med1992232125321640190
  • KrishnanSFurlanJVDuncanNAdherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient surveyHaemophilia201521647025470071
  • RoyalSSchrammWBerntorpEQuality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patientsHaemophilia200281445011886464
  • Garcia-DasiMAznarJAJimenez-YusteVAdherence to prophylaxis and quality of life in children and adolescents with severe haemophilia AHaemophilia201521445846425649244
  • McLaughlinJMWitkopMLLambingAAndersonTLMunnJTortellaBBetter adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophiliaHaemophilia201420450651224517097
  • NijdamAFoppenWvan der SchouwYTMauser-BunchschotenEPSchutgensREFischerKLong-term effects of joint bleeding before starting prophylaxis in severe haemophiliaHaemophilia201622685285827396935
  • BlanchetteVSKeyNSLjungLRManco-JohnsonMJvan den BergHMSrivastavaADefinitions in hemophilia: communication from the SSC of the ISTHJ Thromb Haemost201412111935193925059285
  • National Hemophilia FoundationMASAC recommendation concerning prophylaxis (regular administration of clotting factor concentrate to prevent bleeding)2016 Available from: http://www.hemophilia.org/sites/default/files/document/files/241Prophylaxis.pdfAccessed March 27, 2017
  • den UijlIFischerKvan der BomJGGrobbeeDERosendaalFRPlugIClinical outcome of moderate haemophilia compared with severe and mild haemophiliaHaemophilia2009151839018713246
  • den UijlIBiesmaDGrobbeeDFischerKOutcome in moderate haemophiliaBlood Transfus201412Suppl 1S330S33623245711
  • SrivastavaABrewerAKMauser-BunschotenEPGuidelines for the management of hemophiliaHaemophilia2013191e1e4722776238
  • HayCRProphylaxis in adults with haemophiliaHaemophilia200713Suppl 21015
  • van DijkKFischerKvan der BomJGScheibelEIngerslevJvan den BergHMCan long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the NetherlandsBr J Haematol2005130110711215982352
  • ThornburgCDPhysicians’ perceptions of adherence to prophylactic clotting factor infusionsHaemophilia2008141252918028395
  • Centers for Disease Control and PreventionReport on the Universal Data Collection ProgramAtlantaCDC2005
  • Centers for Disease Control PreventionReport on the Universal Data Collection ProgramAtlantaCDC2014
  • BlanchetteVSMcCreadyMAchonuCAbdolellMRivardGManco-JohnsonMJA survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centresHaemophilia20039Suppl 1192612709033
  • ZappaSMcDanielMMarandolaJAllenGTreatment trends for haemophilia A and haemophilia B in the United States: results from the 2010 practice patterns surveyHaemophilia2012183e140e15322533455
  • American Thrombosis and Hemostasis NetworkATHN Research Report Brief: ATHN Dataset – December 31, 2014ChicagoATHN2015
  • GeraghtySDunkleyTHarringtonCLindvallKMaahsJSekJPractice patterns in haemophilia A therapy: global progress towards optimal careHaemophilia2006121758116409179
  • KhairKLawrenceKButlerRO’SheaEChristieBAAssessment of treatment practice patterns for severe hemophilia A: a global nurse perspectiveActa Haematol2008119211512318367832
  • MeichenbaumDTurkDCFacilitating Treatment AdherenceNew YorkPlenum Press1987
  • HackerMRGeraghtySManco-JohnsonMBarriers to compliance with prophylaxis therapy in haemophiliaHaemophilia20017439239611442644
  • ThornburgCDPipeSWAdherence to prophylactic infusions of factor VIII or factor IX for haemophiliaHaemophilia200612219819916476098
  • ThornburgCDCarpenterSZappaSMunnJLeissingerCCurrent prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United StatesHaemophilia201218456857422335526
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • TencerTRobersonCDuncanNJohnsonKShapiroAA haemophilia treatment centre-administered disease management programme in patients with bleeding disordersHaemophilia200713548048817880433
  • du TreilSRiceJLeissingerCAQuantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia populationHaemophilia200713549350117880435
  • HoSGueDMcIntoshKBucevskaMYangMJacksonSAn objective method for assessing adherence to prophylaxis in adults with severe haemophiliaHaemophilia2014201394323919911
  • DuncanNKronenbergerWRobersonCShapiroAVERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophiliaHaemophilia201016224725519925631
  • DuncanNShapiroAYeXEpsteinJLuoMPTreatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United StatesHaemophilia201218576076522548353
  • WitkopMLMcLaughlinJMAndersonTLMunnJELambingATortellaBPredictors of non-adherence to prescribed prophylactic clotting-factor treatment regimens among adolescent and young adults with a bleeding disorderHaemophilia2016224e245e25027216992
  • KrishnanSVietriJFurlanRDuncanNAdherence to prophylaxis is associated with better outcomes in moderate and severe haemophilia: results of a patient surveyHaemophilia2015211647025470071
  • WalshCEValentinoLAFactor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practicesHaemophilia20091551014102119493018
  • LockJRaatHDuncanNAdherence to treatment in a Western European paediatric population with haemophilia: reliability and validity of the VERITAS-Pro scaleHaemophilia201420561662324861732
  • ArmstrongEPMaloneDCKrishnanSWesslerMJAdherence to clotting factors among persons with hemophilia A or BHematology201520314815325001343
  • HaynesRBTaylorDWSackettDLCompliance in Health CareBaltimoreJohns Hopkins University Press1979
  • LlewellynCDMinersAHLeeCAHarringtonCWeinmanJAThe illness perceptions and treatment beliefs of individuals with severe haemophilia and their role in adherence to home treatmentPsychol Health2003182185200
  • TranDQBarryVAntunARibeiroMSteinSKemptonCLPhysician trust and depression influence adherence to factor replacement: a single-centre cross-sectional studyHaemophilia20172319810427686244
  • PetriniPIdentifying and overcoming barriers to prophylaxis in the management of haemophiliaHaemophilia200713Suppl 2162217685919
  • GueDSquireSMcIntoshKJoining the patient on the path to customized prophylaxis: one hemophilia team explores the tools of engagementJ Multidiscip Healthc2015852753426675989
  • BérubéSMouillardFAmesseCSultanSMotivational techniques to improve self-care in hemophilia: the need to support autonomy in childrenBMC Pediatr201616426754457
  • KhairKMeerabeauLGibsonFSelf-management and skills acquisition in boys with haemophiliaHealth Expect20151851105111323711015
  • BreakeyVRWariasAVIgnasDMWhiteMBlanchetteVSStinsonJNThe value of usability testing for Internet-based adolescent self-management interventions: “Managing Hemophilia Online”BMC Med Inform Decis Mak20131311324094082
  • BreakeyVRIgnasDMWariasAVWhiteMBlanchetteVSStinsonJNA pilot randomized control trial to evaluate the feasibility of an Internet-based self-management and transitional care program for youth with haemophiliaHaemophilia201420678479325311370
  • MicroHealthLearn more: key features Available from: https://microhealth.org/pages/learn-more.htmlAccessed February 5, 2015
  • SchrijversLHKarsMCBeijlevelt-van der ZandeMPetersMSchuurmansMJFischerKUnravelling adherence to prophylaxis in haemophilia: a patients’ perspectiveHaemophilia201521561262125858411
  • BrandBDunnSKulkarniRChallenges in the management of haemophilia on transition from adolescence to adulthoodEur J Haematol20159581303526679395
  • QuonDRedingMGuelcherCUnmet needs in the transition to adulthood: 18- to 30-year-old people with hemophiliaAm J Hematol201590Suppl 2S17S2226619193
  • De MoerloosePUrbancikWvan den BergHMRichardsMA survey of adherence to haemophilia therapy in six European countries: results and recommendationsHaemophilia200814593193818684125
  • SaxenaKBarriers and perceived limitations to early treatment of hemophiliaJ Blood Med20134495623700376
  • OnoOSuzukiYYosikawaKAssessment of haemophilia treatment practice pattern in JapanHaemophilia20091551032103819476508
  • ColomboGLDiMSMancusoMESantagostinoECost-utility analysis of prophylaxis versus treatment on demand in severe hemophilia AClinicoecon Outcomes Res20113556121935333
  • FarrugiaACassarJKimberMCTreatment for life for severe haemophilia A: a cost-utility model for prophylaxis vs. on-demand treatmentHaemophilia2013194e228e23823534877
  • GlobeDRCurtisRGKoerperMAUtilization of care in haemophilia: a resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS)Haemophilia200410Suppl 16370
  • MajumdarSOstrengaALatzmanRDPharmacoeconomic impact of obesity in severe haemophilia children on clotting factor prophylaxis in a single institutionHaemophilia201117471771821323798
  • Iowa Hemophilia Advisory CommitteeReport to the governor and general assembly 20092010 Available from: http://www.idph.state.ia.us/adper/common/pdf/legis/2009_hemophilia.pdfAccessed February 4, 2015
  • TarantinoMDYeXBergstromFSkorijaKLuoMPThe impact of the economic downturn and health care reform on treatment decisions for haemophilia A: patient, caregiver and health care provider perspectivesHaemophilia2013191515823004924
  • CollinsPWBlanchetteVSFischerKBreak-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia AJ Thromb Haemost20097341342019143924
  • FischerKvan der BomJGPrejsRDiscontinuation of prophy-lactic therapy in severe haemophilia: incidence and effects on outcomeHaemophilia20017654455011851751
  • DuncanNAKronenbergerWGKrishnanSShapiroADAdherence to prophylactic treatment in hemophilia as measured using the VERITAS-Pro and annual bleed rate (ABR)Value Health2014173A230
  • McLaughlinJMWitkopMLLambingAAndersonTLMunnJTortellaBBetter adherence to prescribed treatment regimen is related to less chronic pain among adolescents and young adults with moderate or severe haemophiliaHaemophilia201420450651224517097
  • IorioAKrishnanSMyrenKLethagenSMcCormickNKarnerPModeling the impact of potential differences in real-wolrd [sic] adherence with extended-half-life vs. conventional factor VIII and IX on bleedingValue Health2015187A660A661
  • LindvallKColstrupLWollterIMCompliance with treatment and understanding of own disease in patients with severe and moderate haemophiliaHaemophilia2006121475116409174
  • YoungGFrom boy to man: recommendations for the transition process in haemophiliaHaemophilia201218Suppl 5273222757681
  • FischerKValentinoLLjungRBlanchetteVProphylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitorsHaemophilia200814Suppl 319620118510542
  • MillerTAHealth literacy and adherence to medical treatment in chronic and acute illness: a meta-analysisPatient Educ Couns20169971079108626899632
  • KardasPLewekPMatyjasczczykDeterminants of patient adherence: a review of systematic reviewsFront Pharmacol201349123898295
  • HemAwareHemophilia summer camps2010 Available from: https://hemaware.org/story/hemophilia-summer-campsAccessed March 13, 2015
  • HoffmanJACunninghamJRSulehAJMobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, KenyaAm J Prev Med2010391788020537846
  • VolppKGLoewensteinGTroxelABA test of financial incentives to improve warfarin adherenceBMC Health Serv Res2008827219102784
  • WyrwichKWKrishnanSPoonJLAugustePvon MaltzahnRYuRHealth-related quality of life data changes from baseline using Haem-A-QoL scores in the A-LONG clinical study of recombinant factor VIII Fc fusion proteinHaemophilia201420Suppl 3169
  • WyrwichKWKrishnanSPoonJLAugustePvon MaltzahnRYuRHealth-related quality of life data changes over time using Haem-A-QoL scores in the B-LONG clinical study of recombinant factor IX Fc fusion proteinHaemophilia201420Suppl 3173
  • KlamrothRQuonDVKulkarniRSubject-reported changes in physical activity during the A-LONG study of recombinant factor VIII Fc fusion protein (rFVIIIFc) for severe haemophilia AHaemophilia201521Suppl 23425273984
  • WindygaJRagniMPasiKJSubject-reported changes in physical activity during the B-LONG study of recombinant factor IX Fc fusion protein (rFIXFc) for severe haemophilia BHaemophilia201521Suppl 229
  • BosworthHBGrangerBBMendysPMedication adherence: a call for actionAm Heart J2011162341242421884856